The role of fluoroquinolones in respiratory tract infections: Community acquired pneumonia

International Journal of Antimicrobial Agents

Volumn 16, Issue 3, 2000, Pages 281-285

  Garcia Rodriguez J A ^a   Muoz Bellido, J L ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Community acquired pneumonia; Fluoroquinolones; Streptococcus pneumoniae; Treatment

Indexed keywords

AMOXICILLIN; CEFACLOR; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; GREPAFLOXACIN; LEVOFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TROVAFLOXACIN;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; CARDIOTOXICITY; DRUG EFFECT; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE BACTERIUM; HIGH RISK PATIENT; HUMAN; LIVER TOXICITY; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; CLINICAL TRIALS; COMMUNITY-ACQUIRED INFECTIONS; FLUOROQUINOLONES; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMONIA, BACTERIAL; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 0033727756     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00252-1     Document Type: Article

References (29)

1. Aetiology and incidence of community-acquired pneumonia
2. Community-acquired pneumonia
3. Microbiologia de la neumonia atipica comunitaria. Necesidades clnicas y aportaciones de nuevos antibioticos
4. Clinical perspectives on the management of community-acquired pneumonia
5. Guidelines for initial empiric management of adults with community-acquired pneumonia: Diagnosis, assessment of severity and initial antimicrobial therapy
6. Etiology of community-acquired pneumonia in outpatients
7. Ambulatory patients with community-acquired pneumonia: The frequency of atypical pathogens and clinical course
8. Prospective study of community-acquired pneumonia diagnosed and followed-up by private practitioners
9. New emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases
10. Serological investigation of pneumonia as it presents to the physician's office
11. Community-acquired pneumonia requiring hospitalisation
12. The etiology of community acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland
13. Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens
14. The epidemiology of community-acquired pneumonia among hospitalised adults
15. Antimicrobial treatment of community acquired pneumonia in adults: A conference report
16. Guidelines for the management of community acquired pneumonia in adults admitted to hospital
17. Antimicrobial resistance among community acquired pneumonia isolates in Europe: Results from the SENTRY antimicrobial resistance surveillance program
18. Results of the Alexander Project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens
19. Macrolide-resistant S. pneumoniae: A spanish multicenter study of in vitro activities of grepafloxacin and 12 and 300 MRSp strains: Characterization of MRSp phenotypes
20. Multiple pathogens in adult patients admitted with community acquired pneumonia: A one year prospective study of 346 consecutive patients
21. Validation of the therapeutic recommendations of the American Thoracic Society (ATS) guidelines for community acquired pneumonia in hospitalized patients
22. The quinolones: History and overview
23. Pharmacokinetics of the fluoroquinolones
24. Use of fluoroquinolones for the treatment of acute exacerbations of chronic bronchitis
25. Moxifloxacin in community-acquired pneumonia. A bacteriological and clinical meta-analysis
26. Trovafloxacin versus high dose amoxicillin (1 g three times daily) in the treatment of community-acquired bacterial pneumonia
27. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community acquired pneumonia
28. Community acquired pneumonia in adults: Guidelines for management
29. Tratamiento antibiotico empirico de la neumonia adquirida en la comunidad